Phase 3CompletedINTERVENTIONAL
Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization
ClinicalTrials.gov · NCT01183143 · Registry updated: 2018-04-06
- Condition / research focus
- Infertility; Ovulation Induction; In-Vitro Fertilization
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Countries with listed sites
- Germany
- Registry dates and results
- Start: 2004-05-11. Completion: 2006-03-02 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- GONAL-f® (drug) — also listed as: Follitropin alpha
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Please Contact the Merck KGaA Communication Center
Darmstadt, Germany
Site recruitment: Not reported